Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BioCardia Inc | BCDA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.3762 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.3762 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.32 - 2.9199 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.3762 | USD |
BioCardia Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.22M | 21.62M | - | 477k | -11.57M | -0.54 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioCardia News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCDA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.37 | 0.4011 | 0.361 | 0.3775681 | 343,142 | 0.0062 | 1.68% |
| 1 Month | 0.40 | 0.4097 | 0.32 | 0.378603 | 149,720 | -0.0238 | -5.95% |
| 3 Months | 0.4102 | 0.59 | 0.32 | 0.4227517 | 372,470 | -0.034 | -8.29% |
| 6 Months | 0.3725 | 1.55 | 0.32 | 0.9378594 | 1,517,572 | 0.0037 | 0.99% |
| 1 Year | 2.01 | 2.9199 | 0.32 | 0.9426383 | 799,430 | -1.63 | -81.28% |
| 3 Years | 3.64 | 5.0988 | 0.32 | 1.48 | 477,612 | -3.26 | -89.66% |
| 5 Years | 5.24 | 8.60 | 0.32 | 3.07 | 529,616 | -4.86 | -92.82% |
BioCardia Description
| BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack. |
